Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dexamethasone in newly diagnosed sarcoidosis
NL-OMON40492Phase 4Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sarcoidosis comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Health-related quality of life measured by SF-36 physical functioning subscale. Started Nov 2013; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on NL-OMON40492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40492.